15.84
price down icon1.49%   -0.24
 
loading
Schlusskurs vom Vortag:
$16.08
Offen:
$16.22
24-Stunden-Volumen:
2.00M
Relative Volume:
0.87
Marktkapitalisierung:
$3.74B
Einnahmen:
$382.81M
Nettoeinkommen (Verlust:
$68.13M
KGV:
56.57
EPS:
0.28
Netto-Cashflow:
$78.82M
1W Leistung:
-0.38%
1M Leistung:
-1.98%
6M Leistung:
-11.21%
1J Leistung:
+205.79%
1-Tages-Spanne:
Value
$15.73
$16.40
1-Wochen-Bereich:
Value
$15.60
$16.67
52-Wochen-Spanne:
Value
$5.08
$23.64

Adma Biologics Inc Stock (ADMA) Company Profile

Name
Firmenname
Adma Biologics Inc
Name
Telefon
(201) 478-5552
Name
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Name
Mitarbeiter
624
Name
Twitter
@AdmaBiologics
Name
Nächster Verdiensttermin
2024-12-07
Name
Neueste SEC-Einreichungen
Name
ADMA's Discussions on Twitter

Vergleichen Sie ADMA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ADMA
Adma Biologics Inc
15.84 3.74B 382.81M 68.13M 78.82M 0.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-07-19 Fortgesetzt Raymond James Strong Buy
2022-10-13 Eingeleitet Mizuho Buy
2021-11-11 Hochstufung Raymond James Outperform → Strong Buy
2021-11-09 Eingeleitet Cantor Fitzgerald Overweight
2019-06-04 Eingeleitet Jefferies Buy
2019-04-15 Bestätigt H.C. Wainwright Buy
2019-02-07 Fortgesetzt H.C. Wainwright Buy
2017-12-11 Bestätigt Maxim Group Buy
2017-11-14 Hochstufung Raymond James Mkt Perform → Outperform
2017-01-23 Hochstufung Maxim Group Hold → Buy
2016-08-01 Herabstufung Maxim Group Buy → Hold
2016-07-25 Bestätigt Maxim Group Buy
2015-05-13 Bestätigt Maxim Group Buy
2014-12-08 Eingeleitet Oppenheimer Outperform
2014-12-01 Bestätigt Maxim Group Buy
Alle ansehen

Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten

pulisher
12:58 PM

ADMA Biologics announces executive and director compensation changes By Investing.com - Investing.com Nigeria

12:58 PM
pulisher
Feb 21, 2025

Adma Biologics (ADMA) Stock Moves -1.49%: What You Should Know - MSN

Feb 21, 2025
pulisher
Feb 21, 2025

ADMA Biologics announces executive and director compensation changes - Investing.com

Feb 21, 2025
pulisher
Feb 21, 2025

(ADMA) Technical Pivots with Risk Controls - Stock Traders Daily

Feb 21, 2025
pulisher
Feb 20, 2025

Adma Biologics (ADMA) Rises Higher Than Market: Key Facts - MSN

Feb 20, 2025
pulisher
Feb 20, 2025

Adma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN

Feb 20, 2025
pulisher
Feb 19, 2025

ADMA Biologics Gears Up to Report Q4 Earnings: What's in the Cards? - MSN

Feb 19, 2025
pulisher
Feb 18, 2025

Allspring Global Investments Holdings LLC Buys 2,613,482 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Feb 18, 2025
pulisher
Feb 18, 2025

Legato Capital Management LLC Reduces Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

SG Americas Securities LLC Cuts Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Feb 17, 2025
pulisher
Feb 16, 2025

Nkcfo LLC Makes New Investment in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Feb 16, 2025
pulisher
Feb 16, 2025

Empowered Funds LLC Invests $5.68 Million in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Feb 16, 2025
pulisher
Feb 12, 2025

Adma Biologics (ADMA) Stock Moves -0.25%: What You Should Know - Nasdaq

Feb 12, 2025
pulisher
Feb 12, 2025

Pharma Stock Poised to Bounce Off Support - Yahoo Finance

Feb 12, 2025
pulisher
Feb 10, 2025

When the Price of (ADMA) Talks, People Listen - Stock Traders Daily

Feb 10, 2025
pulisher
Feb 09, 2025

ADMA Loses 8.9% in a Month: How Should You Play the Stock? - MSN

Feb 09, 2025
pulisher
Feb 08, 2025

Adma Biologics (ADMA) Advances But Underperforms Market: Key Facts - MSN

Feb 08, 2025
pulisher
Feb 08, 2025

ADMA Biologics, Inc. (NASDAQ:ADMA) Stock Holdings Lifted by Calamos Advisors LLC - MarketBeat

Feb 08, 2025
pulisher
Feb 06, 2025

ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add (NASDAQ:ADMA) - Seeking Alpha

Feb 06, 2025
pulisher
Feb 05, 2025

Exploring Three High Growth Tech Stocks in the United States - Simply Wall St

Feb 05, 2025
pulisher
Feb 05, 2025

Janney Montgomery Scott LLC Sells 6,603 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

Pacer Advisors Inc. Sells 866 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - ETF Daily News

Feb 04, 2025
pulisher
Feb 04, 2025

Engaging In Insider Activity, Kaitlin M. Kestenberg-Messina At ADMA Biologics Exercises Options Worth $28K - Benzinga

Feb 04, 2025
pulisher
Feb 04, 2025

Will Weakness in ADMA Biologics, Inc.'s (NASDAQ:ADMA) Stock Prove Temporary Given Strong Fundamentals? - Simply Wall St

Feb 04, 2025
pulisher
Feb 04, 2025

Pacer Advisors Inc. Has $656,000 Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World

Feb 04, 2025
pulisher
Feb 03, 2025

Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note - Nasdaq

Feb 03, 2025
pulisher
Feb 02, 2025

Short Interest in ADMA Biologics, Inc. (NASDAQ:ADMA) Increases By 11.8% - MarketBeat

Feb 02, 2025
pulisher
Jan 31, 2025

ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Bought by Nisa Investment Advisors LLC - Defense World

Jan 31, 2025
pulisher
Jan 30, 2025

Jim Cramer on ADMA Biologics, Inc. (ADMA): ‘I Would Wait For It To Come Down Before I Would Pull The Trigger’ - Insider Monkey

Jan 30, 2025
pulisher
Jan 30, 2025

8 Stocks on Jim Cramer’s Radar - Insider Monkey

Jan 30, 2025
pulisher
Jan 30, 2025

Jim Cramer Likes This Tech Stock: 'Terrific Business, Niche Business' - Benzinga

Jan 30, 2025
pulisher
Jan 30, 2025

Where are the Opportunities in (ADMA) - Stock Traders Daily

Jan 30, 2025
pulisher
Jan 28, 2025

Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance

Jan 28, 2025
pulisher
Jan 27, 2025

ADMA STOCK DROP ALERT: ADMA Biologics, Inc. Stock Drops over 20%; BFA Law Initiates Securities Fraud Investigation and Urges Investors with Losses to Contact the Firm (Nasdaq:ADMA) - ACCESS Newswire

Jan 27, 2025
pulisher
Jan 26, 2025

ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Inspire Investing LLC - MarketBeat

Jan 26, 2025
pulisher
Jan 25, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics Inc (ADMA) And Encourages Investors to Reach Out - ACCESS Newswire

Jan 25, 2025
pulisher
Jan 24, 2025

Veracity Capital LLC Boosts Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Jan 24, 2025
pulisher
Jan 23, 2025

ADMA Biologics to acquire certain assets from Biotest Pharmaceuticals Corp - Reuters

Jan 23, 2025
pulisher
Jan 22, 2025

Peering Into ADMA Biologics's Recent Short Interest - Benzinga

Jan 22, 2025
pulisher
Jan 22, 2025

Brokers Set Expectations for ADMA Biologics FY2025 Earnings - MarketBeat

Jan 22, 2025
pulisher
Jan 21, 2025

Perpetual Ltd Acquires Shares of 3,632,677 ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Jan 21, 2025
pulisher
Jan 21, 2025

ADMA Stock Catapults 275.7% in a Year: How Should You Play the Stock? - MSN

Jan 21, 2025

Finanzdaten der Adma Biologics Inc-Aktie (ADMA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Adma Biologics Inc-Aktie (ADMA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
ELMS STEVE
Director
Nov 27 '24
Option Exercise
10.80
9,000
97,200
2,124,671
Tade Brad L.
CFO and Treasurer
Nov 22 '24
Sale
21.15
15,000
317,250
199,433
Grossman Adam S
President and CEO
Nov 22 '24
Sale
21.10
48,967
1,033,204
1,989,007
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
Kapitalisierung:     |  Volumen (24h):